Holen Sie sich die Stockscreener-App
5.52
2.65%
-0.15
Schlusskurs vom Vortag:
$5.67
Offen:
$5.74
24-Stunden-Volumen:
5.20M
Relative Volume:
1.21
Marktkapitalisierung:
$1.00B
Einnahmen:
$2.51B
Nettoeinkommen (Verlust:
$-171.15M
KGV:
-5.7303
EPS:
-0.9633
Netto-Cashflow:
$122.59M
1W Leistung:
-9.36%
1M Leistung:
-14.55%
6M Leistung:
+4.74%
1J Leistung:
-34.91%
1-Tages-Spanne:
$5.48
$5.745
1-Wochen-Bereich:
$5.48
$6.0697
52-Wochen-Spanne:
$4.40
$9.8868
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, TEM, TXG, BTSG, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
5.52 | 1.11B | 2.51B | -171.15M | 122.59M | -0.9633 |
VEEV
Veeva Systems Inc
|
273.33 | 45.44B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
76.63 | 15.43B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
93.50 | 11.17B | 638.78M | -22.66M | 122.18M | -0.1744 |
BTSG
Brightspring Health Services Inc
|
60.25 | 11.20B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
97.67 | 7.71B | 646.34M | -512.40M | 202.76M | -6.6871 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-02-26 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-07-25 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Behavioral Health Market Size, Share & Growth Report [2034] - Fortune Business Insights
Teladoc Health stock trades at EUR 5.07 before Xetra opens - AD HOC NEWS
3 Undervalued Healthcare Stocks Invstors Can Buy Right Now - The Motley Fool
Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance Singapore
Net income of Teladoc Health, Inc. – HAN:4LL - TradingView
Reddit and Teladoc Shares Plummet, What You Need To Know - Yahoo Finance
Is Teladoc Health (NYSE:TDOC) the Communication Stocks Stock Everyone's About to Talk About? - Kalkine Media
Teladoc Health Announces Resignation of Chief Legal Officer Adam C. Vandervoort Effective November 1, 2026 - Kalkine Media
Teladoc Health names Jonathan Dorfman as chief legal officer By Investing.com - Investing.com Australia
TDOC Looks 22.7% Undervalued on GF Value™ Amid Legal Leadership Change - GuruFocus
Teladoc Health names Jonathan Dorfman as chief legal officer - Investing.com India
Teladoc Health announces resignation of chief legal officer, names successor - Investing.com
Teladoc Health Announces Chief Legal Officer Transition - The Manila Times
Form 8K Teladoc Inc For: 25 September By Investing.com - Investing.com Canada
TELADOC HEALTH ANNOUNCES CHIEF LEGAL OFFICER TRANSITION - Moomoo
Teladoc Health stock falls 3.46 percent after weak Q2 revenue - AD HOC NEWS
Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Teladoc Health stock holds near USD 6.26 as revenue pressure persists - AD HOC NEWS
Teladoc Health CEO Charles Divita sells $108,681 in shares By Investing.com - Investing.com Australia
Teladoc Health CEO Charles Divita sells $108,681 in shares - Investing.com
Form 4 Teladoc Inc For: 23 September By Investing.com - Investing.com India
The Bull Case For Teladoc Health (TDOC) Could Change Following Weak Q2 Results And Lowered Guidance - Yahoo Finance
Teladoc (TDOC) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
Teladoc Health (TDOC) Slips 2.20% to $6.43, Drifting Toward Key SupportInstitutional Volume - careplusvn.com
Stock awards vest for Teladoc (NYSE: TDOC) CEO as he sells shares to cover taxes - Stock Titan
Teladoc Share PriceTDOC, RNS News, Articles, Quotes, & Charts (NYSE:TDOC) - Proactive financial news
Teladoc: Integrated Care And Free Cash Flow Could Bring It Back To Life - Seeking Alpha
Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144 - moomoo.com
Why Teladoc (TDOC) Outpaced the Stock Market Today - Yahoo Finance
Teladoc Health (TDOC) executive plans 17.8K-share stock sale - Stock Titan
Avoiding Lag: Real-Time Signals in (TDOC) Movement - Stock Traders Daily
2 Beaten-Down Stocks to Avoid Right Now - The Globe and Mail
Here's Why Teladoc's Integrated Care Business Deserves More Attention - The Globe and Mail
Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Officer Bliss Kelly - Moomoo
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - GlobeNewswire
Teladoc Health (TDOC) CEO sells 18,327 shares after stock awards vest - Stock Titan
Equity awards vest for Teladoc Health (NYSE: TDOC) accounting chief - Stock Titan
15,311 stock units vest for Teladoc (TDOC) exec as she sells shares for taxes - Stock Titan
Teladoc Health (TDOC) exec sells shares to cover taxes after 14,928 units vest - Stock Titan
RSU vesting prompts Teladoc (TDOC) executive to sell shares for taxes - Stock Titan
Teladoc Health (NYSE: TDOC) president sells 15,251 shares - Stock Titan
Teladoc Health (NYSE: TDOC) officer plans sale of 9,812 recently vested shares - Stock Titan
The Escalator: GSK, Teladoc, FINN Partners and more - Medical Marketing and Media
Planned stock sale by Teladoc (NYSE: TDOC) officer covers 7,357 shares - Stock Titan
Teladoc Health (NYSE: TDOC) insider lines up 5,439-share stock sale tied to vested awards - Stock Titan
Teladoc (NYSE: TDOC) exec plans stock sale, including shares to cover taxes on vested stock - Stock Titan
Teladoc (NYSE: TDOC) officer plans $39K stock sale - Stock Titan
Teladoc Health (NYSE: TDOC) holder plans 18,327-share Rule 144 sale - Stock Titan
Teladoc Health (NYSE: TDOC) Names Grasher Michael F as CFO and Records New Insider Status - Kalkine Media
Teladoc Health stock rises on a new CFO and steady July results - AD HOC NEWS
Here's Why Investors Should Stay Neutral on TDOC Stock for Now - TradingView
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.13%
2.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):